Previous 10 | Next 10 |
On Nov. 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q3 2021. I curated a list of some of the best-performing hedge funds and looked into their holdings at the end of September 2021. Several common themes appea...
Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the Evercore ISI 4 th Annual HealthCONx Healthcare Conference virtually on Tuesday, November 30th, 2021 at 12:10PM Eastern Standard Time. Interested i...
News Summary: Report covers Waters’ progress on Environmental, Social, and Governance (ESG) initiatives for 2020 through June 2021 Provides increased transparency and data with detailed disclosures in line with the Sustainability Accounting Standards Board (SASB) ...
Image source: The Motley Fool. Waters Corporation (NYSE: WAT) Q3 2021 Earnings Call Nov 2, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Waters Corporation (WAT) Q3 2021 Earnings Call Transcript
Waters Corporation (WAT) Q3 2021 Earnings Conference Call November 2, 2021, 8:00 AM ET Company Participants Udit Batra – President and CEO Amol Chaubal – Senior Vice President and Chief Financial Officer Caspar Tudor – Manager of Investor Relations Conference Call Partici...
Waters (NYSE:WAT): Q3 Non-GAAP EPS of $2.66 beats by $0.30; GAAP EPS of $2.60 beats by $0.29. Revenue of $659.23M (+11.0% Y/Y) beats by $4.29M. Outlook: The company expects full-year 2021 constant-currency sales growth in the range of 15% to 16%. Currency translation is expected to increase f...
Sales of $659 million grew 11% as reported and in constant currency GAAP EPS of $2.60; non-GAAP EPS of $2.66, a 23% increase from prior year Growth led by strong performance in pharmaceutical and industrial end markets Double-digit growth in both instrume...
Waters (NYSE:WAT) is scheduled to announce Q3 earnings results on Tuesday, November 2nd, before market open. The consensus EPS Estimate is $2.36 (+9.3% Y/Y) and the consensus Revenue Estimate is $654.94M (+10.3% Y/Y). Over the last 2 years, WAT has beaten EPS estimates 88% of the time and has...
News Summary: Collaboration to combine the Waters™ BioAccord™ LC-MS System as a bioprocess analyzer with the Sartorius Ambr ® bioreactor system gives bioprocess scientists both faster and direct access to advanced quality characterization information. ...
Partnership will focus on developing analytical solutions to better characterize bioprocesses towards improved quality, yields and efficiency News Summary: Waters and University of Delaware announce a multi-year collaboration to develop technology for analytical charac...
News, Short Squeeze, Breakout and More Instantly...
Waters Corporation (NYSE: WAT) Reports Second Quarter 2024 Financial Results PR Newswire Highlights Sales of $709 million exceeded guidance on a reported basis, declined 4% as reported and 4% in organic constant currency GAAP EPS of $2.40 ; earnin...
Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs PR Newswire News Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throu...
Waters Corporation Schedules Second Quarter 2024 Earnings Conference Call PR Newswire MILFORD, Mass. , July 2, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2024 financial results conference call live on Wednesday, July 31st, 2024 at 8...